MBX Biosciences, Inc. (MBX) Live Share Price, Invest From India

MBX Biosciences, Inc. Stock Performance

as on August 19, 2026 at 6:59 am IST

Day's Low
Day's High
$65.80
Day's Price Range
$69.05
$66.53
1.10%
Downside
3.79%
Upside
52 Week's Low
52 Week's High
$9.63
52-Week Price Range
$72.64
$66.53
85.53%
Downside
9.18%
Upside

MBX Biosciences, Inc. share price movements today

Previous Close: $68.25
Open: $66.47
Volume: 523.1K
Market Cap: $3.3B
Day's Low - High: $65.80 - $69.05
52 Week Low - High: $9.63 - $72.64

MBX Biosciences, Inc. Historical Returns

1 Month Return: + 8.98 %
3 Month Return: + 111.31 %
1 Year Return: + 365.99 %
3 Year Return: 0 %
5 Year Return: 0 %

MBX Biosciences, Inc. Stock Fundamentals & Key Indicators

Check MBX Biosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.3B

EPS (TTM)

-2.4

Dividend Yield

0.00%

PE Ratio (TTM)

-27.95

Industry PE ratio

-13.046547619047619

PEG Ratio

4.793076370395378

Return On Equity TTM

-26.01%

MBX Biosciences, Inc. Stock Valuation

Track how MBX Biosciences, Inc. P/E has moved over time to understand its valuation trends.

MBX Biosciences, Inc. in the last 4 years

Overview
Trends

Lowest (-28.82x)

December 31, 2022

Today (-13.25x)

December 31, 2025

Industry (-13.05x)

December 31, 2025

Highest (-9.96x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -13.25x

MBX Biosciences, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MBX Biosciences, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
MBX Biosciences, Inc.	StrongBuy	$3.3B	NA	-27.95	0.00%	NA
Revolution Medicines	BUY	$43.7B	669.3%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$128.2B	154.86%	29.82	86.04%	NA
Regeneron	BUY	$82.7B	24.1%	19.24	84.86%	0.44999999999999996%

Stock Returns calculator for MBX Biosciences, Inc. Stock including INR - Dollar returns

The MBX Biosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

MBX Biosciences, Inc. investment value today

Current value as on today

₹4,95,409

Returns

₹3,95,409

(+395.41%)

Returns from MBX Biosciences, Inc. Stock

₹3,52,124 (+352.12%)

Dollar Impact

₹43,286 (+43.29%)

Analyst Recommendation on MBX Biosciences, Inc. Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for MBX Biosciences, Inc.. Average target price of $89.5

Indian Investors' Interest in MBX Biosciences, Inc. Stock

Search interest for MBX Biosciences, Inc. Stock has increased by 219% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 20, 2026 to August 19, 2026

Change:219% versus previous 30 day period

MBX Biosciences, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	0	0	0	-
Operating Income	-13	-16	-19	-18	-26	-21	-23	-25	-27	-40
EBITDA	-12	-15	-18	-15	-23	-19	-21	-22	-23	-40
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-12	-15	-18	-15	-23	-19	-21	-22	-23	-37
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-12	-15	-18	-15	-23	-19	-21	-22	-23	-37
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

MBX Biosciences, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	0
Operating Income	-25	-35	-68	-98
EBITDA	-25	-32	-61	-86
Interest Expense	0	-	-	-
Depreciation	0	0	0	0
Income Before Tax	-26	-32	-61	-86
Income Tax Expense	-	-	-	-
Net Income	-26	-32	-61	-86
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

MBX Biosciences, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-12	-15	-18	-15	-23	-19	-21	-22	-23	-37
Operating Cash Flow	-10	-13	-14	-16	-22	-17	-21	-18	-20	-22
Investing Cash Flow	15	-7	-100	-67	3	25	17	-129	-97	29
Financing Cash Flow	0	-1	235	0	0	1	187	0	87	2
Change in Cash	35	-22	120	-83	-19	9	183	-147	-29	8

MBX Biosciences, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-26	-32	-61	-86
Operating Cash Flow	-23	-31	-54	-79
Investing Cash Flow	-11	-30	-160	-83
Financing Cash Flow	46	69	234	189
Change in Cash	11	6	18	25

Mutual Funds that own MBX Biosciences, Inc. Stock

Check out the Mutual Funds with significant holdings in MBX Biosciences, Inc..

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	2.993546%	1441695
MUTUAL FUND SERIES TRUST	1.848002%	890000
Fidelity Securities Fund	1.55471%	748750
T. ROWE PRICE HEALTH SCIENCES FUND, INC.	1.497731%	721309
Fidelity Advisor Series VII	1.255396%	604600

See all

Global Institutional Holdings in MBX Biosciences, Inc.

Funds	Holdings
Vanguard	3.67%
iShares	3.41%
Richard Driehaus	2.11%
Michael Rockefeller	1.87%
SPDR	0.77%

See all

Insights on MBX Biosciences, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, MBX stock has moved up by 120.3%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 481.6% return, outperforming this stock by 113.2%

About MBX Biosciences, Inc.

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is Canvuparatide (MBX 2109), a parathyroid hormone peptide prodrug, which is in Phase 3 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing Imapextide (MBX 1416), a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 2 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.

Organisation	MBX Biosciences, Inc.
Headquarters	11711 North Meridian Street, Carmel, IN, United States, 46032
Industry	Biotechnology
CEO	Mr. Steven L. Hoerter
E-voting on shares	Click here to vote

Key Management of MBX Biosciences, Inc.

Name	Title
Mr. John W. Smither CPA	Chief Financial Officer
Mr. Pete De Spain	Senior Vice President of Investor Relations & Corporate Communications
Dr. Michael A. Dorato DABT, Ph.D.	Sr. Vice President of Discovery & Non-Clinical Development
Dr. Chatan Charan Ph.D.	Senior VP of Pharmaceutical Development & Chemistry, Manufacturing and Controls
Mr. Steven L. Hoerter	Executive Chairperson, CEO & President
Dr. Salomon Azoulay M.D.	Chief Medical Officer
Ms. Michelle Graham	Chief Human Resources Officer
Mr. Mark Hope	Senior Vice President of Regulatory & Quality
Dr. Andreas Moraitis M.D.	Senior Vice President of Clinical Development
Mr. Peter Kent Hawryluk MBA	Executive Officer

FAQs

What is MBX Biosciences, Inc. share price today?

MBX Biosciences, Inc. share price today is $66.53 as on August 19, 2026 at 1:29 am IST at the close of the market. MBX Biosciences, Inc. share today touched a day high of $69.05 and a low of $65.80.

What is the 52 week high and 52 week low for MBX Biosciences, Inc. share?

MBX Biosciences, Inc. share touched a 52 week high of $72.64 on August 5, 2026 and a 52 week low of $9.63 on September 12, 2025. MBX Biosciences, Inc. stock price today i.e. August 19, 2026 at 1:29 am IST is closed at $66.53,which is 8.41% down from its 52 week high and 590.86% up from its 52 week low.

What is MBX Biosciences, Inc.'s market capitalisation today?

MBX Biosciences, Inc. market capitalisation is $0.00T as on August 19, 2026 at 1:29 am IST.

How to invest in MBX Biosciences, Inc. Stock (MBX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for MBX Biosciences, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MBX Biosciences, Inc. Shares that will get you 0.0225 shares as per MBX Biosciences, Inc. share price of $66.53 per share as on August 19, 2026 at 1:29 am IST.

What is the minimum amount required to buy MBX Biosciences, Inc. Stock (MBX) from India?

Indian investors can start investing in MBX Biosciences, Inc. (MBX) shares with as little as ₹95.67 or $1 (as of August 19, 2026 at 3:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in MBX Biosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on August 19, 2026 at 3:41 am IST). Based on MBX Biosciences, Inc. share’s latest price of $66.53 as on August 19, 2026 at 1:29 am IST, you will get 0.1503 shares of MBX Biosciences, Inc.. Learn more about fractional shares .